Clinical Trial Update: OH2 Oncolytic Viral Therapy in Advanced Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of OH2 oncolytic viral therapy for advanced bladder cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• OH2

Snippet

Sponsor: Binhui Biopharmaceutical Co., Ltd. | Conditions: Advanced Bladder Carcinoma | Phase 2 | Status: TERMINATED